Selvita (WSE: SLV) today announced that the first patient enrolled in the Phase 1b study of company’s selective CDK8 inhibitor, SEL120, has received the first dose. SEL120 is being initially investigated in the treatment of patients with acute myeloid leukemia (AML) ...
Chainalysis, the blockchain analysis company, today announced the roll-out of its cryptocurrency compliance solution for BITBOX, the digital asset exchange operated by LINE, the mobile messaging platform. The need for stricter compliance operations for cryptocurrency businesses and social and ...
It has been revealed in recently published whitepaper, that among the many aspects of implementing AI, there are some significant cost reductions when dealing with lenders. The report shows, that the implementation of AI-powered identity verification could reduce Know ...